Psychiatry :: First Mani Bhaumik Award to UW Scientist for Insights into Brain’s Neuroplasticity

The Cousins Center for Psychoneuroimmunology at UCLA has named University of Wisconsin’s Richard Davidson as the first recipient of The Mani Bhaumik Award. The award was established earlier this year to support scientists in the international community who advance the understanding of the brain and the conscious mind in healing through visionary research, books and education. Bhaumik, co-inventor of the laser technology that made LASIK surgery possible, has funded the annual $10,000 award.

Crohn’s Disease :: Promising results in tough-to-treat crohn’s disease patients

Abbott announced results from a study showing HUMIRA? (adalimumab) induced significantly higher rates of clinical remission compared to placebo in patients with moderately to severely active Crohn’s disease who lost response to, or were intolerant to, infliximab therapy. The data is being presented simultaneously at the American College of Gastroenterology (ACG) annual meeting in Las Vegas and the United European Gastroenterology Week (UEGW) in Berlin.

Colorectal Cancer :: Mesalazine to prevent colorectal cancer in IBD

Speaking at a Ferring-sponsored symposium on the occasion of the 14th United European Gastroenterology Week (UEGW) congress, Christoph Gasche, Associate Professor of Medicine, Medical University of Vienna, Austria presented the findings of an in-vitro study which for the first time demonstrates a mode of action by which mesalazine may reduce the risk of colorectal cancer in Inflammatory Bowel Disease (IBD) patients.

Pain :: Gene variation affects pain sensitivity and risk of chronic pain

A new NIH-funded study shows that a specific gene variant in humans affects both sensitivity to short-term (acute) pain in healthy volunteers and the risk of developing chronic pain after one kind of back surgery. Blocking increased activity of this gene after nerve injury or inflammation in animals prevented development of chronic pain.

Eyelash Implants :: What is eyelash implants or eyelash transplantation?

Eyelash implant or transplant surgery is a cosmetic, elective procedure that is performed to add eyelashes to the upper eyelid. The patient receives a local anesthetic. To perform eyelash implants or transplantation, the surgeon obtains a graft of hair from the nape of the neck. The graft is divided into single-hair grafts, and any excess fat, dermis, and epidermis are trimmed in order to make each graft very fine.

Eyelash Implants :: Eyelash transplants gaining popularity

Eyelash transplant surgery is gaining popularity as the new must-have procedure for women and sometimes even men. “Longer, thicker lashes are an ubiquitous sign of beauty. Eyelash transplantation does for the eyes what breast augmentation does for the figure,” said Dr Alan Bauman, a leading proponent of eyelash transplants. “This is a brand new procedure for the general public (and) it is going to explode”.

Heart Disease :: Special bra for women who have had heart surgery

Dr. Kathryn King, a University of Calgary researcher developed the new compression bra as a result of complaints from women who experience numbness, tingling and shooting sensations in their breasts after heart surgery. King’s design stops the weight of the breast from putting pressure on the surgical wound and also allows women to wear a bra immediately after the operation, instead of three or four days later.

Smoking :: Stop smoking before routine surgery

Health chiefs in Norfolk plan to save money by encouraging smokers to quit before undergoing routine operations. Doctors say they are following a programme tried in Newcastle-under-Lyme, Staffs, and health authority hope that the move will improve general health and cut hospital costs. They say research shows that smokers take more time to recover from surgery – and therefore have longer and more expensive stays in hospital – and are more likely to suffer complications.

Tennis Elbow :: New biologic treatment for tennis elbow may replace surgery

A person suffering from tennis elbow may not have to look any further than his or her own body for the most effective treatment, according to a study published in the November issue of The American Journal of Sports Medicine. Specially prepared platelets taken from the patient which are then re-injected into the tendon of the affected elbow provides more relief than more commonly-used therapies which have failed to yield results, often resulting in surgery, concludes study authors Allan Mishra MD and Terri Pavelko, PAC, PT, of the Menlo Medical Clinic, Stanford University Medical Center, Menlo Park, Calif.

Health :: Glivec, imatinib approved for five rare life threatening disorders

In another important milestone, Glivec? (imatinib) has received US regulatory approval to help patients with five distinct and potentially life-threatening disorders, representing the first time that a regulatory authority has ever simultaneously approved one targeted medicine for so many disorders. With today’s decision, and in only five years, Glivec has now been approved in the US for seven diseases, including two solid tumors and five blood disorders with molecular targets known to be inhibited by the drug.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack